Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

PubWeight™: 1.78‹?› | Rank: Top 3%

🔗 View Article (PMID 21930293)

Published in Thromb Res on September 17, 2011

Authors

Marcello Di Nisio1, Francesco Baudo, Benilde Cosmi, Armando D'Angelo, Andrea De Gasperi, Alessandra Malato, Mario Schiavoni, Alessandro Squizzato, Italian Society for Thrombosis and Haemostasis

Author Affiliations

1: Department of Medicine and Aging, Centre for Aging Sciences, CeSI, University GD'Annunzio Foundation, Chieti, Italy. mdinisio@unich.it

Articles citing this

Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72

A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care (2013) 1.67

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med (2013) 1.29

Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care (2014) 1.11

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care (2013) 1.06

Clinical use and the Italian demand for antithrombin. Blood Transfus (2013) 0.96

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J (2016) 0.82

Massive Bleeding as the First Clinical Manifestation of Metastatic Prostate Cancer due to Disseminated Intravascular Coagulation with Enhanced Fibrinolysis. Case Rep Hematol (2016) 0.82

Possible FDA-approved drugs to treat Ebola virus infection. Infect Dis Poverty (2015) 0.77

Reproducing a Prospective Clinical Study as a Computational Retrospective Study in MIMIC-II. AMIA Annu Symp Proc (2015) 0.75

Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure. World J Gastroenterol (2015) 0.75

Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. World J Gastroenterol (2015) 0.75

Performance Evaluation of Five Different Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Predicting Mortality in Patients with Complicated Sepsis. J Korean Med Sci (2016) 0.75

Renal artery thrombosis secondary to sepsis-induced disseminated intravascular coagulation in acute pyelonephritis. Kidney Res Clin Pract (2012) 0.75

The SISET incorrectly cited the JAAM DIC scoring system. Thromb Res (2011) 0.75

Articles by these authors

D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med (2006) 6.62

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica (2009) 3.63

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost (2011) 2.75

Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost (2002) 2.44

Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica (2002) 2.43

A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood (2007) 2.28

Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol (2004) 2.10

Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment. J Hepatol (2007) 2.09

A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms. Eur J Clin Pharmacol (2012) 2.07

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ (2011) 1.96

Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels. Haematologica (2004) 1.73

Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol (2005) 1.67

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood (2012) 1.65

Early alterations of red blood cell rheology in critically ill patients. Crit Care Med (2009) 1.58

Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J (2013) 1.58

Comments on Reinhart et al.: consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med (2012) 1.47

Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice. Blood (2012) 1.46

Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis. Thromb Haemost (2011) 1.45

Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost (2015) 1.43

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med (2014) 1.42

Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia. Thromb Haemost (2012) 1.40

Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost (2011) 1.40

Diagnosis of deep vein thrombosis. Semin Thromb Hemost (2006) 1.39

The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation. Haematologica (2005) 1.39

The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: a systematic review and meta-analysis. Thromb Haemost (2012) 1.37

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes (2010) 1.36

Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients. Thromb Haemost (2009) 1.34

Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement. Crit Care (2013) 1.24

Should we still offer split-liver transplantation for two adult recipients? A retrospective study of our experience. Liver Transpl (2008) 1.24

Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab (2009) 1.17

Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation (2003) 1.13

Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost (2006) 1.12

Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review. Thromb Haemost (2009) 1.12

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood (2009) 1.09

Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost (2009) 1.07

Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res (2009) 1.07

Drug-induced anti-factor VIII antibodies: a systematic review. Med Sci Monit (2007) 1.06

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood (2008) 1.05

Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica (2002) 1.04

Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg (2008) 1.00

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99

An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS One (2012) 0.99

Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res (2012) 0.99

Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost (2010) 0.97

Diagnosis, laboratory aspects and management of acquired hemophilia A. Intern Emerg Med (2010) 0.96

Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg (2004) 0.96

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96

Tailoring warfarin induction doses to reflect individual and disease-specific factors. Am J Med (2005) 0.95

Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis. PLoS One (2013) 0.95

Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. Transfusion (2010) 0.94

Telomere length in peripheral blood mononuclear cells is associated with folate status in men. J Nutr (2009) 0.94

Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost (2010) 0.93

Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res (2009) 0.93

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thromb Haemost (2008) 0.93

Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation (2003) 0.92

The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients. Haematologica (2005) 0.92

Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice. EMBO Mol Med (2013) 0.91

Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab (2004) 0.91

Biliary complications after living donor adult liver transplantation. Transpl Int (2006) 0.90

The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost (2009) 0.89

Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes (2004) 0.89

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol (2012) 0.89

Complex cardiac surgery in Jehovah's Witnesses with chronic renal failure. J Cardiothorac Vasc Anesth (2007) 0.89

Evidence and clinical judgment: vena cava filters. Thromb Haemost (2014) 0.88

Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. Blood (2002) 0.88

Seasonal and monthly variability in the incidence of venous thromboembolism. A systematic review and a meta-analysis of the literature. Thromb Haemost (2011) 0.88

Selecting patients for home treatment of deep vein thrombosis: the problem of cancer. Haematologica (2002) 0.88

Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial. Ann Thorac Surg (2006) 0.88

Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost (2003) 0.87

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Cardiology (2005) 0.86

Tranexamic acid for trauma. Lancet (2010) 0.86

Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica (2006) 0.85

Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion. Retina (2006) 0.85

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. Br J Haematol (2006) 0.84

Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. Arch Intern Med (2004) 0.84

What is the next step in D-dimer research? Education of physicians. Intern Emerg Med (2006) 0.84

Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms. Ann Hematol (2009) 0.84

No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease. Thromb Res (2002) 0.84

Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84

Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Haematologica (2008) 0.83

Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux. J Thorac Cardiovasc Surg (2009) 0.83

Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res (2009) 0.83

Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med (2015) 0.82

Bone marrow hypoplasia complicating tacrolimus (FK506) therapy. Int J Hematol (2004) 0.82

Intraoperative moderate acute normovolemic hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg (2004) 0.81

Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options. Int J Antimicrob Agents (2011) 0.81

Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes. Diabetes Care (2013) 0.81

Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res (2009) 0.81

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. Thromb Res (2007) 0.81

Evidence and clinical judgment: Treatment of cerebral vein thrombosis. Thromb Haemost (2010) 0.81

Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients. Leuk Lymphoma (2008) 0.81

Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction. Clin Biochem (2006) 0.80

The protein C pathway and sepsis. Thromb Res (2011) 0.80

Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? Thromb Haemost (2009) 0.80

Use of recombinant factor VIIa during orthotopic liver transplantation. Liver Transpl (2006) 0.80